Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• UBS Reiterates Buy Rating on StandardAero Inc (SARO)
• UBS Reiterates Buy Rating on Constellation Brands (STZ) Following Q1 Results